As a follow up to my last post, today Abbott announced the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle Libre 3 system.
All we know as far as timing is it will be available later this year, but you can sign up at the previous link in this post to be notified when it will be at pharmacies.
3 thoughts on “Abbot’s Freestyle Libre 3 gets FDA approval”
Pingback: Abbot’s Freestyle Libre 3 gets FDA approval – Diabetic Daily
hoping it is a lot better than 2. I get so FRUSTRATED with 2 sometimes. A while ago, mine suddenly leaped from a day in mid May of this year to Sept and then October of 21. It often reads 20 or more higher or lower than what I am, which eventually evens out in the long run. The A1C is much better, but still use contour finger sticks to verify. The libre finger sticks are much further off, so don’t use those at all anymore. I use a reader instead of a phone because I am not often with wifi and the phone needs a lot more pocket. However, when I look back to how Diabetes management used to be, it is an amazing wonder!!! :o)
I’m curious about Libre. I use Dexcom G6. Dexcom was always supposed to be more accurate but I think Libre has caught up. I asked my endo what he thought and he didn’t like that you can’t callibrate the Libre, and of course, I’d need it covered by Medicare, which it isn’t yet. Will be interesting to know if you find the v3 better than the v2 Kris.